{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:10:31Z","timestamp":1782313831709,"version":"3.54.5"},"reference-count":117,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Group B Streptococcus (GBS) is a component of the natural human microbiota, colonizing the genitourinary tract and the distal gastrointestinal tract. Due to its production of numerous virulence factors, GBS can cause infections in pregnant women, newborns, and immunocompromised individuals. In newborns, GBS infection may present as severe pneumonia, meningitis, or sepsis. Screening for maternal GBS colonization, combined with intrapartum antibiotic prophylaxis for colonized women, is currently regarded as the most effective strategy for preventing neonatal GBS infections. However, growing concerns regarding antibiotic resistance and the negative impact of antibiotics on the neonatal microbiome have intensified the search for alternative approaches. These include the development of a vaccine and methods to reduce vaginal colonization in pregnant women.<\/jats:p>","DOI":"10.3390\/pathogens15010022","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T09:58:34Z","timestamp":1766570314000},"page":"22","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["New Strategies for Preventing Perinatal Group B Streptococcus (GBS) Infections"],"prefix":"10.3390","volume":"15","author":[{"given":"Dorota","family":"Kaminska","sequence":"first","affiliation":[{"name":"Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Ratajczak","sequence":"additional","affiliation":[{"name":"Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Nowicka","sequence":"additional","affiliation":[{"name":"Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2192-3715","authenticated-orcid":false,"given":"Jolanta","family":"Dlugaszewska","sequence":"additional","affiliation":[{"name":"Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7468-2604","authenticated-orcid":false,"given":"Marzena","family":"Gajecka","sequence":"additional","affiliation":[{"name":"Chair and Department of Genetics and Pharmaceutical Microbiology, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland"},{"name":"Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","article-title":"Group B Streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.jmb.2019.01.035","article-title":"The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen","volume":"431","author":"Armistead","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_3","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease\u2014Revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","article-title":"Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797","volume":"135","author":"Naat","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rosini, R., and Margarit, I. (2015). Biofilm formation by Streptococcus agalactiae: Influence of environmental conditions and implicated virulence factors. Front. Cell. Infect. Microbiol., 5.","DOI":"10.3389\/fcimb.2015.00006"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e20191881","DOI":"10.1542\/peds.2019-1881","article-title":"Management of Infants at Risk for Group B Streptococcal Disease","volume":"144","author":"Puopolo","year":"2019","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2013.01.009","article-title":"An overview of global GBS epidemiology","volume":"31","author":"Heath","year":"2013","journal-title":"Vaccine"},{"key":"ref_8","first-page":"20499361221142732","article-title":"Transmission of Group B Streptococcus in late-onset neonatal disease: A narrative review of current evidence","volume":"9","author":"Miselli","year":"2022","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Burcham, L.R., Spencer, B.L., Keeler, L.R., Runft, D.L., Patras, K.A., Neely, M.N., and Doran, K.S. (2019). Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0226699"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/INF.0000000000001345","article-title":"Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen-Year Experience From Two Australian Tertiary Pediatric Facilities","volume":"36","author":"Bartlett","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1651-2227.2009.01510.x","article-title":"Late and ultra late onset Streptococcus B meningitis: Clinical and bacteriological data over 6 years in France","volume":"99","author":"Guilbert","year":"2010","journal-title":"Acta Paediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/0890334413479448","article-title":"Group B Streptococcus Colonization of Breast Milk of Group B Streptococcus Positive Mothers","volume":"29","author":"Janota","year":"2013","journal-title":"J. Hum. Lact."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Freudenhammer, M., Karampatsas, K., Le Doare, K., Lander, F., Armann, J., Acero Moreno, D., Boyle, M., Buxmann, H., Campbell, R., and Chalker, V. (2021). Invasive Group B Streptococcus Disease with Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.617925"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Shabayek, S., and Spellerberg, B. (2018). Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00437"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.00117-07","article-title":"Serotype IX, a Proposed New Streptococcus agalactiae Serotype","volume":"45","author":"Slotved","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ippolito, D.L., James, W.A., Tinnemore, D., Huang, R.R., Dehart, M.J., Williams, J., Wingerd, M.A., and Demons, S.T. (2010). Group B streptococcusserotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-336"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cid\/cit337","article-title":"Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991\u20132010","volume":"57","author":"Lamagni","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.2807\/1560-7917.ES2014.19.23.20825","article-title":"Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): Emergence of a new epidemic type IV\/clonal complex 17 clone","volume":"19","author":"Florindo","year":"2014","journal-title":"Eurosurveillance"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal Colonization with Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2295805","DOI":"10.1080\/14767058.2023.2295805","article-title":"Serotype distribution, antimicrobial resistance, and molecular characterization of group B Streptococcus isolates from Chinese pregnant woman","volume":"37","author":"Chen","year":"2024","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S0950268813000848","article-title":"Serotype and surface protein gene distribution of colonizing group B streptococcus in women in Egypt","volume":"142","author":"Shabayek","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/382881","article-title":"Characterization of Group B Streptococci Recovered from Infants with Invasive Disease in England and Wales","volume":"38","author":"Weisner","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Salloum, M., Van Der Mee-Marquet, N., Valentin-Domelier, A.-S., and Quentin, R. (2011). Diversity of Prophage DNA Regions of Streptococcus agalactiae Clonal Lineages from Adults and Neonates with Invasive Infectious Disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020256"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Perme, T., Golparian, D., Bombek Ihan, M., Rojnik, A., Lu\u010dovnik, M., Kornhauser Cerar, L., Fister, P., Lozar Krivec, J., Grosek, \u0160., and Ihan, A. (2020). Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001\u20132018. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05599-y"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Creti, R., Imperi, M., Berardi, A., Lindh, E., Alfarone, G., Pataracchia, M., and Recchia, S. (2021). The Italian Network on Neonatal and Infant GBS Infections Invasive Group B Streptococcal Disease in Neonates and Infants, Italy, Years 2015\u20132019. Microorganisms, 9.","DOI":"10.3390\/microorganisms9122579"},{"key":"ref_27","first-page":"395","article-title":"Occurrence of the hypervirulent ST-17 clone of Streptococcus agalactiae in pregnant women and newborns","volume":"66","author":"Gosiewski","year":"2012","journal-title":"Przegl. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41598-024-54521-y","article-title":"Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland","volume":"14","author":"Ratajczak","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/IAI.01014-13","article-title":"BsaB, a Novel Adherence Factor of Group B Streptococcus","volume":"82","author":"Jiang","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/mmi.13097","article-title":"Srr2, a multifaceted adhesin expressed by ST-17 hypervirulent Group B Streptococcus involved in binding to both fibrinogen and plasminogen","volume":"97","author":"Six","year":"2015","journal-title":"Mol. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Al Safadi, R., Amor, S., Hery-Arnaud, G., Spellerberg, B., Lanotte, P., Mereghetti, L., Gannier, F., Quentin, R., and Rosenau, A. (2010). Enhanced Expression of lmb Gene Encoding Laminin-Binding Protein in Streptococcus agalactiae Strains Harboring IS1548 in scpB-lmb Intergenic Region. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010794"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/603540","article-title":"BibA Induces Opsonizing Antibodies Conferring In Vivo Protection against Group B Streptococcus","volume":"200","author":"Santi","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.20092594","article-title":"The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates","volume":"207","author":"Tazi","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3201\/eid2611.201669","article-title":"Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007\u20132019","volume":"26","author":"Plainvert","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Martins, E.R., Pedroso-Roussado, C., Melo-Cristino, J., Ramirez, M., and The Portuguese Group for the Study of Streptococcal Infections (2017). Streptococcus agalactiae Causing Neonatal Infections in Portugal (2005\u20132015): Diversification and Emergence of a CC17\/PI-2b Multidrug Resistant Sublineage. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00499"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1128\/IAI.01613-07","article-title":"Sortase A Utilizes an Ancillary Protein Anchor for Efficient Cell Wall Anchoring of Pili in Streptococcus agalactiae","volume":"76","author":"Nobbs","year":"2008","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/595564","article-title":"Preventing Bacterial Infections with Pilus-Based Vaccines: The Group B Streptococcus Paradigm","volume":"199","author":"Margarit","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Springman, A.C., Lacher, D.W., Waymire, E.A., Wengert, S.L., Singh, P., Zadoks, R.N., Davies, H.D., and Manning, S.D. (2014). Pilus distribution among lineages of group b streptococcus: An evolutionary and clinical perspective. BMC Microbiol., 14.","DOI":"10.1186\/1471-2180-14-159"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, J., Li, W., Li, N., and Wang, B. (2023). Immunization with Multiple Virulence Factors Provides Maternal and Neonatal Protection against Group B Streptococcus Serotypes. Vaccines, 11.","DOI":"10.3390\/vaccines11091459"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/17460913.4.2.201","article-title":"Understanding the Regulation of Group B Streptococcal Virulence Factors","volume":"4","author":"Rajagopal","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Liu, Y., and Liu, J. (2022). Group B Streptococcus: Virulence Factors and Pathogenic Mechanism. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122483"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2451173","DOI":"10.1080\/21505594.2025.2451173","article-title":"Virulence and pathogenicity of group B Streptococcus: Virulence factors and their roles in perinatal infection","volume":"16","author":"Megli","year":"2025","journal-title":"Virulence"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"21003","DOI":"10.1074\/jbc.M114.553073","article-title":"FbsC, a Novel Fibrinogen-binding Protein, Promotes Streptococcus agalactiae-Host Cell Interactions","volume":"289","author":"Buscetta","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/mmi.13357","article-title":"PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of group B Streptococcus","volume":"101","author":"Buscetta","year":"2016","journal-title":"Mol. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.actbio.2008.01.009","article-title":"Interactions of the streptococcal C5a peptidase with human fibronectin","volume":"4","author":"Hull","year":"2008","journal-title":"Acta Biomater."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1074\/jbc.M608279200","article-title":"Identification of a Glycosaminoglycan Binding Region of the Alpha C Protein That Mediates Entry of Group B Streptococci into Host Cells","volume":"282","author":"Baron","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1084\/jem.20122753","article-title":"A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta","volume":"210","author":"Whidbey","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0042-2018","article-title":"Biology of Oral Streptococci","volume":"6","author":"Abranches","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Rinaudo, C.D., Rosini, R., Galeotti, C.L., Berti, F., Necchi, F., Reguzzi, V., Ghezzo, C., Telford, J.L., Grandi, G., and Maione, D. (2010). Specific Involvement of Pilus Type 2a in Biofilm Formation in Group B Streptococcus. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009216"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Konto-Ghiorghi, Y., Mairey, E., Mallet, A., Dum\u00e9nil, G., Caliot, E., Trieu-Cuot, P., and Dramsi, S. (2009). Dual Role for Pilus in Adherence to Epithelial Cells and Biofilm Formation in Streptococcus agalactiae. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000422"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micpath.2018.05.020","article-title":"Influence of environmental and genotypic factors on biofilm formation by clinical isolates of group B streptococci","volume":"121","author":"Nie","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1128\/AEM.03627-13","article-title":"Acidic pH Strongly Enhances In Vitro Biofilm Formation by a Subset of Hypervirulent ST-17 Streptococcus agalactiae Strains","volume":"80","author":"Martinelli","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41390-022-02375-3","article-title":"Evolving antibiotic resistance in Group B Streptococci causing invasive infant disease: 1970\u20132021","volume":"93","author":"Sabroske","year":"2023","journal-title":"Pediatr. Res."},{"key":"ref_54","first-page":"157","article-title":"High Incidence of Macrolide and Tetracycline Resistance Among Streptococcus agalactiae Strains Isolated from Clinical Samples in Tehran, Iran","volume":"9","author":"Emaneini","year":"2014","journal-title":"Maedica"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Berbel, D., Gonz\u00e1lez-D\u00edaz, A., De Egea, G.L., C\u00e0mara, J., and Ardanuy, C. (2022). An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122316"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jgar.2023.10.007","article-title":"Molecular typing and antimicrobial resistance of group B Streptococcus clinical isolates in Saudi Arabia","volume":"35","author":"Alzayer","year":"2023","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s10096-020-03992-8","article-title":"Streptococcus agalactiae in pregnant women: Serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy)","volume":"39","author":"Genovese","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Bolukaoto, J.Y., Monyama, C.M., Chukwu, M.O., Lekala, S.M., Nchabeleng, M., Maloba, M.R.B., Mavenyengwa, R.T., Lebelo, S.L., Monokoane, S.T., and Tshepuwane, C. (2015). Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Res. Notes, 8.","DOI":"10.1186\/s13104-015-1328-0"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences","volume":"158","author":"Cox","year":"2014","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00125-023-06047-7","article-title":"Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes","volume":"67","author":"Gajecka","year":"2024","journal-title":"Diabetologia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jinf.2020.05.002","article-title":"The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review","volume":"81","author":"Dierikx","year":"2020","journal-title":"J. Infect."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Prescott, S., Dreisbach, C., Baumgartel, K., Koerner, R., Gyamfi, A., Canellas, M., St. Fleur, A., Henderson, W.A., and Trinchieri, G. (2021). Impact of Intrapartum Antibiotic Prophylaxis on Offspring Microbiota. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.754013"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/archdischild-2021-322590","article-title":"Impact of intrapartum antibiotics on the infant gastrointestinal microbiome: A narrative review","volume":"107","author":"Diamond","year":"2022","journal-title":"Arch. Dis. Child."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0000000000000928","article-title":"Influence of Intrapartum Antibiotic Prophylaxis for Group B Streptococcus on Gut Microbiota in the First Month of Life","volume":"62","author":"Corvaglia","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/IDR.S203454","article-title":"A Vaccine Against Group B Streptococcus: Recent Advances","volume":"13","author":"Ramkhelawon","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Pena, J.M.S., Lannes-Costa, P.S., and Nagao, P.E. (2024). Vaccines for Streptococcus agalactiae: Current status and future perspectives. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1430901"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Procter, S.R., Gon\u00e7alves, B.P., Paul, P., Chandna, J., Seedat, F., Koukounari, A., Hutubessy, R., Trotter, C., Lawn, J.E., and Jit, M. (2023). Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004068"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOP.0000000000001223","article-title":"20 million pregnant women with group B streptococcus carriage: Consequences, challenges, and opportunities for prevention","volume":"35","author":"Paul","year":"2023","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for Maternally Administered Vaccine for Infant Group B Streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00049-18","DOI":"10.1128\/CMR.00049-18","article-title":"Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets","volume":"31","author":"Furfaro","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1016\/j.vaccine.2017.08.085","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States","volume":"35","author":"Kim","year":"2017","journal-title":"Vaccine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of Maternal Antibody Deficiency with Susceptibility to Neonatal Group B Streptococcal Infection","volume":"294","author":"Baker","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2021.03.007","article-title":"Uptake of vaccination in pregnancy","volume":"76","author":"Sebghati","year":"2021","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Gupalova, T., Leontieva, G., Kramskaya, T., Grabovskaya, K., Bormotova, E., Korjevski, D., and Suvorov, A. (2018). Development of experimental GBS vaccine for mucosal immunization. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196564"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Bedeley, E., Gori, A., Yeboah-Manu, D., and Diallo, K. (2021). Control of Streptococcal Infections: Is a Common Vaccine Target Achievable Against Streptococcus agalactiae and Streptococcus pneumoniae. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.658824"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.1093\/infdis\/jiaf096","article-title":"A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B Streptococcus Vaccine Administered Concomitantly with Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals","volume":"231","author":"Smith","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e03223-24","DOI":"10.1128\/spectrum.03223-24","article-title":"Impact of antibiotics on membrane vesicle production in Group B Streptococcus","volume":"13","author":"Pell","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_78","unstructured":"(2024, November 16). A Phase 1\/2, Randomized, Placebo-Controlled, Observer-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Nonpregnant Women and Pregnant Women 18 to 40 Years of Age and Their Infants. Clinicaltrials.Gov; Report No.: NCT03765073, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03765073."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/jix565","article-title":"Vaccination with a Latch Peptide Provides Serotype-Independent Protection Against Group B Streptococcus Infection in Mice","volume":"217","author":"Lin","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.vaccine.2023.04.024","article-title":"Vaccine value profile for Group B streptococcus","volume":"41","author":"Trotter","year":"2023","journal-title":"Vaccine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e01227-25","DOI":"10.1128\/spectrum.01227-25","article-title":"Expansion of the Group B Streptococcus serotype repertoire via gene acquisition from other streptococcal species","volume":"13","author":"Sharp","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_82","unstructured":"(2024, November 17). Projekt JUNO. Available online: https:\/\/www.gbsgen.net\/."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1574-695X.2009.00618.x","article-title":"The vaginal bacterial communities of Japanese women resemble those of women in other racial groups","volume":"58","author":"Zhou","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00414-011-0660-8","article-title":"Vaginal microbial flora analysis by next generation sequencing and microarrays; can microbes indicate vaginal origin in a forensic context?","volume":"126","author":"Benschop","year":"2012","journal-title":"Int. J. Leg. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3920\/BM2015.0174","article-title":"Is the role of human female reproductive tract microbiota underestimated?","volume":"8","author":"Gajecka","year":"2017","journal-title":"Benef. Microbes"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.resmic.2017.04.001","article-title":"The role of lactic acid production by probiotic Lactobacillus species in vaginal health","volume":"168","author":"Tachedjian","year":"2017","journal-title":"Res. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"37437","DOI":"10.1038\/srep37437","article-title":"The lectin-like protein 1 in Lactobacillus rhamnosus GR-1 mediates tissue-specific adherence to vaginal epithelium and inhibits urogenital pathogens","volume":"6","author":"Petrova","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/1751-7915.12799","article-title":"Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides","volume":"10","author":"Allonsius","year":"2017","journal-title":"Microb. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Liu, P., Lu, Y., Li, R., and Chen, X. (2023). Use of probiotic lactobacilli in the treatment of vaginal infections: In Vitro and in vivo investigations. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1153894"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Avitabile, E., Menotti, L., Croatti, V., Giordani, B., Parolin, C., and Vitali, B. (2024). Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179168"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/jcmm.13496","article-title":"Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans","volume":"22","author":"Wasfi","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"104463","DOI":"10.1016\/j.micpath.2020.104463","article-title":"The impact of Lactobacillus on group B streptococcal interactions with cells of the extraplacental membranes","volume":"148","author":"Shiroda","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12934-023-02053-x","article-title":"Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms","volume":"22","author":"Giordani","year":"2023","journal-title":"Microb. Cell Factories"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12941-020-0347-4","article-title":"Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: A critical review","volume":"19","author":"Kalia","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"103692","DOI":"10.1016\/j.micpath.2019.103692","article-title":"In-vitro effect of vaginal lactobacilli against group B Streptococcus","volume":"136","author":"Marziali","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1472-765X.2006.01934.x","article-title":"Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells","volume":"43","author":"Zarate","year":"2006","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00284-014-0524-9","article-title":"Effect of Two Probiotic Strains of Lactobacillus on In Vitro Adherence of Listeria monocytogenes, Streptococcus agalactiae, and Staphylococcus aureus to Vaginal Epithelial Cells","volume":"68","author":"Ortiz","year":"2014","journal-title":"Curr. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jam.12642","article-title":"Phenotypic surface properties (aggregation, adhesion and biofilm formation) and presence of related genes in beneficial vaginal lactobacilli","volume":"117","author":"Mendoza","year":"2014","journal-title":"J. Appl. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/IJWH.S77956","article-title":"Vaginal Lactobacillus: Biofilm formation in vivo\u2014Clinical implications","volume":"7","author":"Ventolini","year":"2015","journal-title":"Int. J. Womens Health"},{"key":"ref_101","first-page":"113","article-title":"In-Vitro evaluation of the antagonistic effects of the probiotics Lactobacillus rhamnosus HN001 and Florajen 3 against group B Streptococci","volume":"7","author":"Ephraim","year":"2012","journal-title":"Int. J. Probiotics Prebiotics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/IAI.00409-15","article-title":"Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization","volume":"83","author":"Patras","year":"2015","journal-title":"Infect. Immun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/jam.12739","article-title":"Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model","volume":"118","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/aji.12445","article-title":"Immunomodulation of Lactobacillus reuteri CRL1324 on Group B Streptococcus Vaginal Colonization in a Murine Experimental Model","volume":"75","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_105","first-page":"54708","article-title":"A Murine Model of Group B Streptococcus Vaginal Colonization","volume":"117","author":"Patras","year":"2016","journal-title":"J. Vis. Exp."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/infdis\/jix395","article-title":"Group B Streptococcus and the Vaginal Microbiota","volume":"216","author":"Rosen","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14767050410001668617","article-title":"The International Infections in Pregnancy Study: Group B streptococcal colonization in pregnant women","volume":"15","author":"Whitney","year":"2004","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tjog.2016.06.003","article-title":"Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial","volume":"55","author":"Ho","year":"2016","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100748","DOI":"10.1016\/j.ajogmf.2022.100748","article-title":"A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms","volume":"5","author":"Hanson","year":"2023","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Mart\u00edn, V., C\u00e1rdenas, N., Oca\u00f1a, S., Mar\u00edn, M., Arroyo, R., Beltr\u00e1n, D., Badiola, C., Fern\u00e1ndez, L., and Rodr\u00edguez, J.M. (2019). Rectal and Vaginal Eradication of Streptococcus agalactiae (GBS) in Pregnant Women by Using Lactobacillus salivarius CECT 9145, A Target-specific Probiotic Strain. Nutrients, 11.","DOI":"10.3390\/nu11040810"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"19745","DOI":"10.1038\/s41598-020-76896-4","article-title":"Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy","volume":"10","author":"Farr","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1080\/14767058.2019.1650907","article-title":"Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: A midwifery-led double-blind randomized controlled pilot trial","volume":"34","author":"Sharpe","year":"2021","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Yi, M., Wang, H., Wang, M., Cao, J., Gao, F., Ke, X., Liu, Z., Liu, Y., and Lu, M. (2021). Efficient Inhibition of Streptococcus agalactiae by AIEgen-Based Fluorescent Nanomaterials. Front. Chem., 9.","DOI":"10.3389\/fchem.2021.715565"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pdpdt.2015.08.007","article-title":"In Vitro photoinactivation of bovine mastitis related pathogens","volume":"13","author":"Sellera","year":"2016","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.freeradbiomed.2020.09.003","article-title":"Increased photoinactivation stress tolerance of Streptococcus agalactiae upon consecutive sublethal phototreatments","volume":"160","author":"Pieranski","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Pieranski, M.K., Rychlowski, M., and Grinholc, M. (2021). Optimization of Streptococcus agalactiae Biofilm Culture in a Continuous Flow System for Photoinactivation Studies. Pathogens, 10.","DOI":"10.3390\/pathogens10091212"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Piera\u0144ski, M.K., Kosi\u0144ski, J.G., Szymczak, K., Sadowski, P., and Grinholc, M. (2023). Antimicrobial Photodynamic Inactivation: An Alternative for Group B Streptococcus Vaginal Colonization in a Murine Experimental Model. Antioxidants, 12.","DOI":"10.3390\/antiox12040847"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/1\/22\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:13:11Z","timestamp":1766571191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/1\/22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["pathogens15010022"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15010022","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}